Ads
related to: edwards heart valve replacement- Important Risk Info
Read important risk information
about TAVR by Edwards
- TAVR Procedure
Learn what to expect
from your TAVR Procedure.
- Informed Decision Guide
Use our shared decision-making tool
to make a better treatment decision
- Hear From TAVR Patients
See stories of patients treated
for SAS with symptoms.
- Important Risk Info
Search results
Results from the WOW.Com Content Network
The device is used to perform minimally invasive surgery for people with heart valve disease. Edwards on Thursday forecast 2024 TAVR sales in the range of $4.0 billion to $4.3 billion, compared ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
Transcatheter aortic valve replacement (TAVR) device, Edwards' lead product, which has been facing rising competition from other med-tech peers, posted a 12.9% rise in revenue to $979.4 million.
Sales of the company's Transcatheter aortic valve replacement (TAVR) device, which helps in a type of heart surgery, rose 9% to $992 million in the second quarter.
An artificial heart valve is a one-way valve implanted into a person's heart to replace a heart valve that is not functioning properly (valvular heart disease). Artificial heart valves can be separated into three broad classes: mechanical heart valves, bioprosthetic tissue valves and engineered tissue valves.
Transcatheter aortic valve replacement (TAVR) is the implantation of the aortic valve of the heart through the blood vessels without actual removal of the native valve (as opposed to the aortic valve replacement by open heart surgery, surgical aortic valve replacement, AVR).
Ads
related to: edwards heart valve replacement